Ziegler et al. reveal distinct genetic and epigenetic mechanisms underlying Alzheimer’s disease and cerebral small vessel disease within neurovascular cells, identifying immune-related AD risk and broad neurovascular involvement in SVD. They highlight novel regulatory pathways and potential therapeutic targets, advancing understanding of these comorbid conditions for future treatment strategies.
